Here are the latest quarterly results of NEULAND LABS. For more details, see the NEULAND LABS financial fact sheet and NEULAND LABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,559 | 2,212 | 2,937 | 2,693 | 4,071 | 3,630 | 4,177 | 3,928 | |
Other income | Rs m | 6 | 5 | 2 | 9 | 81 | 20 | 30 | 21 | |
Turnover | Rs m | 2,565 | 2,217 | 2,939 | 2,702 | 4,151 | 3,650 | 4,208 | 3,949 | |
Expenses | Rs m | 2,170 | 1,926 | 2,244 | 2,152 | 2,872 | 2,661 | 2,803 | 2,716 | |
Gross profit | Rs m | 389 | 286 | 693 | 541 | 1,199 | 969 | 1,375 | 1,213 | |
Depreciation | Rs m | 125 | 128 | 132 | 133 | 135 | 136 | 145 | 151 | |
Interest | Rs m | 28 | 29 | 32 | 27 | 43 | 22 | 44 | 37 | |
Profit before tax | Rs m | 243 | 135 | 532 | 389 | 1,102 | 832 | 1,216 | 1,045 | |
Tax | Rs m | 25 | 35 | 147 | 84 | 256 | 213 | 323 | 231 | |
Profit after tax | Rs m | 218 | 100 | 385 | 305 | 845 | 619 | 892 | 814 | |
Gross profit margin | % | 15.2 | 12.9 | 23.6 | 20.1 | 29.4 | 26.7 | 32.9 | 30.9 | |
Effective tax rate | % | 10.3 | 26.0 | 27.7 | 21.5 | 23.3 | 25.6 | 26.6 | 22.1 | |
Net profit margin | % | 8.5 | 4.5 | 13.1 | 11.3 | 20.8 | 17.0 | 21.4 | 20.7 | |
Diluted EPS | Rs | 17.0 | 7.8 | 30.0 | 23.8 | 65.9 | 48.2 | 69.6 | 63.4 | |
Diluted EPS (TTM) | Rs | 49.7 | 50.7 | 64.8 | 78.5 | 127.5 | 167.9 | 207.5 | 247.1 | |
Subscriber Feature |
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.